is saxenda a glp 1 drug GLP-1 analogs, new trend in obesity treatment, become even more effective < Pharma < Article What's New in Obesity Treatment?
Description
11,12 Glucose-Lowering Effects: DPP-4 inhibitors effectively reduce both fasting and postprandial glucose levels
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
Phase III studies are ongoing to further investigate the efficacy and safety of survodutide in obesity management
Novo Nordisk A/S: CagriSema Demonstrated Superior HbA1c Reduction of 1.91 Percent Points and Weight Loss of 14.2 Percent in Adults with Type 2 Diabetes in the REIMAGINE 2 Trial
Lancet (2021) 398:26276
A randomized, double-blind, placebo-controlled, parallel-group study showed that among the patients with T2DM treated with EX monotherapy, EX could improve glycated hemoglobin, fasting blood glucose, and postprandial blood glucose control, reduce weight, improve cell function, and adjust blood pressure
doi: 10.1080/20013078.2019.1617000 64 GriffithsSK
